S2M logo

S2Medical AB (publ) Stock Price

OM:S2M Community·SEK 8.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

S2M Share Price Performance

SEK 0.01
-0.00 (-5.45%)
SEK 0.01
-0.00 (-5.45%)
Price SEK 0.01

S2M Community Narratives

There are no narratives available yet.

Snowflake Analysis

Good value with adequate balance sheet.

4 Risks
1 Reward

S2Medical AB (publ) Key Details

SEK 15.5m

Revenue

SEK 1.8m

Cost of Revenue

SEK 13.6m

Gross Profit

SEK 16.4m

Other Expenses

-SEK 2.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0033
88.11%
-17.86%
0%
View Full Analysis

About S2M

Founded
2013
Employees
7
CEO
Petter Sivler
WebsiteView website
www.s2m.se

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications. In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

Recent S2M News & Updates

Recent updates

No updates